KaloBios Comments on Recent Scientific Publication Reporting Significantly Higher Risk of Death Associated With Chagas Infection
25 mai 2017 10h18 HE
|
KaloBios Pharmaceuticals Inc.
BRISBANE, Calif., May 25, 2017 (GLOBE NEWSWIRE) -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare...